Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 11,648,000 | 11,985,000 | 11,624,000 | 11,703,000 | 11,073,000 |
| Cost of Goods | 2,471,000 | 2,356,000 | 2,291,000 | 2,452,000 | 2,841,000 |
| Gross Profit | 9,177,000 | 9,629,000 | 9,333,000 | 9,251,000 | 8,232,000 |
| Operating Expenses | 7,490,000 | 7,771,000 | 7,176,000 | 7,698,000 | 5,702,000 |
| Operating Income | 1,687,000 | 1,858,000 | 2,157,000 | 1,553,000 | 2,530,000 |
| Pre-tax Income | 1,687,000 | 1,858,000 | 2,157,000 | 1,553,000 | 2,530,000 |
| Income Tax | 404,000 | -514,000 | 605,000 | 492,000 | 501,000 |
| Net Income Continuous | 1,283,000 | 2,372,000 | 1,552,000 | 1,061,000 | 2,029,000 |
| Minority Interests | 5,000 | N/A | 6,000 | 6,000 | 8,000 |
| Net Income | $1,278,000 | $2,372,000 | $1,546,000 | $1,055,000 | $2,021,000 |
| EPS Basic Total Ops | 0.60 | 1.08 | 0.70 | 0.47 | 0.90 |
| EPS Basic Continuous Ops | 0.60 | 1.07 | 0.70 | 0.48 | 0.91 |
| EPS Diluted Total Ops | 0.59 | 1.07 | 0.69 | 0.47 | 0.89 |
| EPS Diluted Continuous Ops | 0.59 | 1.07 | 0.69 | 0.47 | 0.90 |
| EBITDA(a) | $4,271,000 | $4,437,000 | $4,884,000 | $4,265,000 | $5,198,000 |